|Bid||0.0000 x 900|
|Ask||0.0000 x 1100|
|Day's Range||3.4200 - 3.5200|
|52 Week Range||2.7000 - 10.9600|
|Beta (5Y Monthly)||0.50|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 11, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.88|
CHESTER, N.Y., July 28, 2021--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report second quarter 2021 financial results on Wednesday, August 11, 2021. KORU Medical’s management will host a conference call
Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Repro Med Systems, Inc. ( NASDAQ:KRMD ) shareholders have seen the share price descend 25% over the month. But that...